Relic Technologies Q1 FY27 Results: Standalone Profit Up, Group Posts Loss

Net loss reportedExceptional itemResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-11.8%Reaction day

₹67.99

prior close

₹67.99

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-11.9% vs market

Other Financial Services peers, median of 84sector+0.0%-11.8% vs sector

On the reaction day the stock moved 11.9 pts less than Nifty Microcap 250 and 11.8 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-11.8+0.2-11.9+0.0-11.8

Next day

-7.6+0.2-7.9+0.0-7.6

+1.5+0.4+1.1-0.3+1.8

+2.2+0.7+1.5+0.0+2.2

-4.3+0.1-4.4-0.2-4.1

+3.0+0.7+2.3-1.1+4.0

-4.4+1.2-5.6-0.9-3.5

15d

+3.0+0.7+2.2-2.0+5.0

+0.0-1.2+1.2-1.8+1.8

-4.0-1.1-2.9-5.7+1.7

—————

UpDownMarket · Nifty Microcap 250Sector · Other Financial Services peers, median of 84Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY26-27 unaudited results (ended June 30, 2026) with unmodified auditor opinion. Standalone: revenue Rs 21.15 lakh from new pharma trading, net profit Rs 21.47 lakh versus Rs 9.84 lakh year ago, EPS Rs 0.38. Consolidated: revenue Rs 35.49 lakh, net loss Rs 102.75 lakh as subsidiaries lost Rs 124.22 lakh, EPS loss Rs 1.16.

Likely market impact

Standalone profits rise from new pharma trading; consolidated losses persist from subsidiaries. Mixed results, monitor subsidiary turnaround.